Amgen Takes Sensipar Dispute to Appellate Court

Drug Industry Daily
A dispute between Amgen and generics maker Cipla is headed to appellate court after a federal judge turned aside Amgen’s effort to get Cipla to stop making generics of the blockbuster Sensipar while the two companies litigate over rights.

To View This Article:


Subscribe To Drug Industry Daily